Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is an increasingly recognized disorder associated with high mortality rates. The pathomechanisms of CUA are only partially understood ...
SCOTTSDALE, AZ--(Marketwired - Aug 2, 2013) - Hope Pharmaceuticals today announced that the United States Patent and Trademark Office issued U. S. patent no. 8,496,973, titled "Sodium ...
Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Use of sodium thiosulfate to treat calciphylaxis in patients on peritoneal dialysis can be ...
Cisplatin chemotherapy and surgery are effective treatments for children with standard-risk hepatoblastoma but may cause considerable and irreversible hearing loss. This trial compared cisplatin with ...
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the U.S.
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Sodium Thiosulfate Injection contains the active ingredient sodium ...
The US Food and Drug Administration (FDA) has approved sodium thiosulfate (Pedmark, Fennec Pharmaceuticals) injection to reduce the risk for ototoxicity associated with cisplatin in pediatric patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback